-
1دورية أكاديمية
المؤلفون: Li Li, Chunhua Xu, Wei Wang, Qian Zhang
المصدر: The Clinical Respiratory Journal, Vol 18, Iss 5, Pp n/a-n/a (2024)
مصطلحات موضوعية: efficacy, elderly patients, immunotherapy, non‐small cell lung cancer, PD‐1/PD‐L1 inhibitors, safety, Diseases of the respiratory system, RC705-779
وصف الملف: electronic resource
-
2دورية أكاديمية
المؤلفون: Lei Yang, Xiujing Cui, Fengpeng Wu, Zifeng Chi, Linlin Xiao, Xuan Wang, Zezheng Liang, Xiaoning Li, Qiyao Yu, Xueqin Lin, Chao Gao
المصدر: Frontiers in Immunology, Vol 15 (2024)
مصطلحات موضوعية: PD-1/PD-L1 inhibitors, neoadjuvant immunotherapy, rectal cancer (RC), systematic review, neoadjuvant chemoradiotherapy, Immunologic diseases. Allergy, RC581-607
وصف الملف: electronic resource
العلاقة: https://www.frontiersin.org/articles/10.3389/fimmu.2024.1392499/fullTest; https://doaj.org/toc/1664-3224Test
-
3دورية أكاديمية
المؤلفون: Li Liu, Shuo Zhang, Hai-Yan Yang, Chun-Hua Zhou, Yi Xiong, Nong Yang, Ye Tian
المصدر: Lipids in Health and Disease, Vol 23, Iss 1, Pp 1-14 (2024)
مصطلحات موضوعية: Advanced NSCLC, Lipid metabolism, Anlotinib alongside PD-1/PD-L1 inhibitors, Therapeutic effect, Nutritional diseases. Deficiency diseases, RC620-627
وصف الملف: electronic resource
العلاقة: https://doaj.org/toc/1476-511XTest
-
4دورية أكاديمية
المؤلفون: Yanling Wang, Xiaoxuan Yang, Jia Ma, Shenglan Chen, Ping Gong, Ping Dai
المصدر: Heliyon, Vol 10, Iss 5, Pp e27077- (2024)
مصطلحات موضوعية: Thyroid dysfunction, Efficacy, Immune checkpoint inhibitors, PD-1/PD-L1 inhibitors, Advanced lung cancer, Science (General), Q1-390, Social sciences (General), H1-99
وصف الملف: electronic resource
العلاقة: http://www.sciencedirect.com/science/article/pii/S2405844024031086Test; https://doaj.org/toc/2405-8440Test
-
5دورية أكاديمية
المؤلفون: Jing Yang, Heming Kang, Liyang Lyu, Wei Xiong, Yuanjia Hu
المصدر: Discover Oncology, Vol 14, Iss 1, Pp 1-12 (2023)
مصطلحات موضوعية: Combination therapy, Targeted therapy, Immuno-oncology therapy, PD-1/PD-L1 inhibitors, Kinase inhibitors, Bispecific antibodies, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282
وصف الملف: electronic resource
العلاقة: https://doaj.org/toc/2730-6011Test
-
6دورية أكاديمية
المؤلفون: Chi Zhang, Fengtao Wei, Wenhan Ma, Jingbo Zhang
المصدر: Frontiers in Immunology, Vol 15 (2024)
مصطلحات موضوعية: PD-1/PD-L1 inhibitors, solid tumors, cardiotoxicity, vascular toxicity, meta-analysis, Immunologic diseases. Allergy, RC581-607
وصف الملف: electronic resource
العلاقة: https://www.frontiersin.org/articles/10.3389/fimmu.2024.1255825/fullTest; https://doaj.org/toc/1664-3224Test
-
7دورية أكاديمية
المؤلفون: Li Liu, Shuo Zhang, Hai-Yan Yang, Chun-Hua Zhou, Yi Xiong, Nong Yang, Ye Tian
مصطلحات موضوعية: Biochemistry, Medicine, Molecular Biology, Pharmacology, Cancer, Environmental Sciences not elsewhere classified, Biological Sciences not elsewhere classified, Advanced NSCLC, Lipid metabolism, Anlotinib alongside PD-1/PD-L1 inhibitors, Therapeutic effect
الإتاحة: https://doi.org/10.6084/m9.figshare.24995537.v1Test
https://figshare.com/articles/journal_contribution/Additional_file_1_of_Lipid_alterations_play_a_role_in_the_integration_of_PD-1_PD-L1_inhibitors_and_anlotinib_for_the_treatment_of_advanced_non_small-cell_lung_cancer/24995537Test -
8دورية أكاديمية
المؤلفون: 志龙 黄
مصطلحات موضوعية: Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies), Tumour immunology, PD-1/PD-L1 inhibitors, colorectal cancers, randomized controlled trial, retrospective study, prospective studies
الإتاحة: https://doi.org/10.6084/m9.figshare.25036127.v3Test
https://figshare.com/articles/journal_contribution/_PD-1_L1__/25036127Test -
9دورية أكاديمية
المؤلفون: Chenxi Sun, Huixian Chen, Yongjing Wang, Chengyun Zheng
المصدر: Hematology, Vol 28, Iss 1 (2023)
مصطلحات موضوعية: PD-1/PD-L1 inhibitors, nivolumab, pembrolizumab, camrelizumab, safety, efficacy, Diseases of the blood and blood-forming organs, RC633-647.5
وصف الملف: electronic resource
العلاقة: https://doaj.org/toc/1607-8454Test
-
10دورية أكاديمية
المصدر: Cancer Cell International, Vol 23, Iss 1, Pp 1-19 (2023)
مصطلحات موضوعية: PD-1/PD-L1 inhibitors, Immune checkpoint inhibitors, Overall survival, Progression-free survival, Pathological complete response, Adverse events, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282, Cytology, QH573-671
وصف الملف: electronic resource
العلاقة: https://doaj.org/toc/1475-2867Test